Alignment Healthcare (ALHC) EV to EBITDA (2021 - 2026)

Alignment Healthcare (ALHC) has reported EV to EBITDA for 6 consecutive years, with 84.7 the latest figure, recorded in Q2 2026.

• For the quarter ending Q2 2026, EV to EBITDA rose 11.24% year-over-year to 84.7; the trailing twelve-month figure through Jun 2026 stood at 48.89 (down 93.18% YoY), and the FY2025 full-year result was 76.86, up 442.38% from the prior year.
• EV to EBITDA retreated to 84.7 in Q2 2026 per ALHC's latest filing, from 124.77 in the prior quarter.
• Across five years, EV to EBITDA topped out at 2001.18 in Q1 2025 and bottomed at 1399.1 in Q4 2025.
• Historically, EV to EBITDA has averaged 13.53 across 5 years, with a median of 34.59 in 2023.
• The widest YoY moves for EV to EBITDA: up 10949.48% in 2025, down 1204.39% in 2025.
• Over 5 years, EV to EBITDA stood at 37.81 in 2022, then grew by 4.03% to 36.29 in 2023, then tumbled by 195.6% to 107.26 in 2024, then plunged by 1204.39% to 1399.1 in 2025, then soared by 106.05% to 84.7 in 2026.
• According to Business Quant data, EV to EBITDA over the past three periods registered 84.7, 124.77, and 1399.1 for Q2 2026, Q1 2026, and Q4 2025 respectively.